In addition to the latest Virtus LifeSci Biotech Clinical Trials ETF (BBC) stock price, this page includes 21 charts that add a unique perspective to the latest stock quote.
Tip: It’s not polite to stare. Except with ETFvest charts. Staring at a chart may help you uncover some unique insights.
The Virtus LifeSci Biotech Clinical Trials ETF (BBC) stock price and stock chart below provides intra-day data for the current/most recent trading day.
To help provide a sense of the near-term trend, the following chart illustrates the daily closing price for Virtus LifeSci Biotech Clinical Trials ETF (BBC) over the past year.
For a longer-term perspective, the following chart presents price performance since 2000 (or since inception) for Virtus LifeSci Biotech Clinical Trials ETF (BBC).
It’s been said that investors should not fight the Fed. To that end, the following chart presents the daily closing price performance for Virtus LifeSci Biotech Clinical Trials ETF (BBC) (blue line) as well as the S&P 500 (gray line) from the last close before the Federal Reserve began increasing the benchmark fed funds rate (March 15, 2022) to today.
War can certainly impact people’s lives, the global order, and a fund’s performance. To that end, the following chart presents the daily closing price performance for Virtus LifeSci Biotech Clinical Trials ETF (BBC) (blue line) as well as the S&P 500 (gray line) from the last close before Russia fully invaded Ukraine (February 24, 2022) to today.
The S&P 500 peaked (and entered a bear market) on January 3, 2022. So how has Virtus LifeSci Biotech Clinical Trials ETF (BBC) (blue line) and the S&P 500 (gray line) performed from that significant S&P 500 peak? The following post-S&P 500 peak chart answers that question.
So how has Virtus LifeSci Biotech Clinical Trials ETF (BBC) (blue line) and the S&P 500 (gray line) performed from the day before inflation picked up on Febuary 10, 2021 until today? The following post-inflation chart answers that question.
How much does Virtus LifeSci Biotech Clinical Trials ETF (BBC) gain (or lose) in a day? The following chart illustrates how frequently certain daily price movements occur. The end result is a visual representation of the ETF’s volatility.
While extreme price gains are by definition rare, the following chart gives a sense of what is possible by presenting the biggest daily gains of Virtus LifeSci Biotech Clinical Trials ETF (BBC) since 2000 (or since its inception).
So what were the biggest losses? The chart below answers that question by presting the biggest daily losses for Virtus LifeSci Biotech Clinical Trials ETF (BBC) since 2000 (or since its inception).
So how much has Virtus LifeSci Biotech Clinical Trials ETF (BBC) declined from its peak? When the blue line is at 0%, the ETF is (or was) at its peak. Otherwise, it is (or was) below its peak by the amount indicated on the y-axis.
The chart below illustrates the performance of Virtus LifeSci Biotech Clinical Trials ETF (BBC) (blue line) and S&P 500 (gray line) during the Covid bear market.
The chart below illustrates the performance of Virtus LifeSci Biotech Clinical Trials ETF (BBC) (blue line) and S&P 500 (gray line) during the financial crisis bear market.
The chart below presents the relative strength of Virtus LifeSci Biotech Clinical Trials ETF (BBC) as compared to the benchmark S&P 500. When the blue line in the chart is trending up, the ETF is outperforming the S&P 500 and when it is moving down it is underperforming.
The following chart illustrates the relative strength of Virtus LifeSci Biotech Clinical Trials ETF (BBC) as compared to the popular/tech-laden Nasdaq 100. When the blue line in the chart is moving up, the ETF is outperforming the Nasdaq 100 and when it is trending down — underperforming.
The chart below presents the relative strength of Virtus LifeSci Biotech Clinical Trials ETF (BBC) as compared to the Russell 2000 (i.e., small-cap stock index). When the blue line in the chart is working its way higher, the ETF is outperforming the Russell 2000 and when it is headed lower it is underperforming.
The following chart illustrates the inflation-adjusted performance for Virtus LifeSci Biotech Clinical Trials ETF (BBC). The U.S. dollar tends to lose purchasing power over time. The following chart adjusts for the ever shrinking dollar so you can see what real price gains the ETF is actually providing.
So how is Virtus LifeSci Biotech Clinical Trials ETF (BBC) performing when priced in that other world currency — gold? The following gold-adjusted chart ansers that question.
The following chart presents the average year performance for Virtus LifeSci Biotech Clinical Trials ETF (BBC). There is a season for all things. Well, at least some things.
The chart below provides a slightly differnet perspective to seasonality. It illustrates the average year for Virtus LifeSci Biotech Clinical Trials ETF (BBC) divided by the S&P 500. When the blue line is trending higher, the ETF has outperformed the S&P 500 on average during that part of the year. When the blue line is moving lower, the ETF has underperformed the S&P 500 — on average.
Does Virtus LifeSci Biotech Clinical Trials ETF (BBC) tend to perform better on a particular day of the week? The following average weekday chart provides the answer.
